Frazier Lifesciences Acquisition 10-Q2022 Q1 Quarterly report

Content analysis

Filed: 11 May 22, 7:29pm

Date: May 11, 2022

/s/ James N. Topper

James N. Topper

Chief Executive Officer

(Principal Executive Officer)

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	Coll freshman Bad

New words: adverse, andthe, assessment, automaticallyconvert, conflict, context, country, creation, deficiency, doubt, economic, economy, energy, expanded, expend, expended, February, geopolitical, globally, immaterial, impair, increasingly, inflation, military, misstatement, omitted, Oversight, primarily, properly, Russia, Russian, technical, terrorism, Ukraine, unusual, variant, world

Removed: ASU, August, automatically, briefly, Central, Certification, Certifying, common, communication, consult, Dated, Description, document, duly, enhance, enhanced, Europe, exhibit, existing, expressly, Extension, factor, formatted, furnished, hedging, hereunto, increased, Inline, instance, Interactive, Japan, Label, Linkbase, manner, merge, Mine, negotiating, occurring, open, Organization, Page, participation, paying, personnel, positive, principal, pursued, Qualitative, quantitative, reconcile, registrant, removing, research, Reserve, ruled, Safety, Schema, scope, selecting, Senior, settlement, structuring, Taxonomy, Topper, travel, undersigned, Unregistered, XBRL, yield, yielded

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Frazier Lifesciences Acquisition similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Frazier Lifesciences Acquisition Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James N. Topper, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.